Cancer drug destroys tumours in pre-clinical trials

October 9, 2014 by Kim Lyell, QIMR Berghofer Medical Research Institute
Cancer drug destroys tumours in pre-clinical trials

Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumours in pre-clinical trials.

The study led by Dr Glen Boyle at QIMR Berghofer's Cancer Drug Mechanisms group found a single injection of the drug EBC-46 led to rapid breakdown of tumours in a range of human tumour models.

Dr Boyle says the findings of the pre-clinical trials at QIMR Berghofer suggest the drug could be effective in human patients.

"We were able to achieve very strong results injecting EBC-46 directly into melanoma models, as well as cancers of the head, neck and colon," Dr Boyle said.

"In most cases the single injection treatment caused the loss of viability of cancer cells within four hours, and ultimately destroyed the tumours."

Dr Boyle says EBC-46 works in part by triggering a cellular response which effectively cuts off the blood supply to the tumour.

"In more than 70 per cent of pre-clinical cases, the response and cure was long-term and enduring, with very little relapse over a period of 12 months."

EBC-46 is a compound extracted from the fruit of the Blushwood tree which is found in north Queensland rainforests.

EBC-46 was discovered by the Queensland biotechnology company EcoBiotics.

The is being developed as a human and veterinary pharmaceutical through EcoBiotics' subsidiary company QBiotics.

The has been used by practising veterinarians to successfully destroy or shrink tumours in pets – including dogs, cats and horses.

QBiotics is currently undertaking formal veterinary clinical trials with EBC-46 in Australia and the USA.

A final regulatory approval is still required for a human Phase I clinical trial.

Dr Boyle says QIMR Berghofer is keen to pursue further research to determine if EBC-46 could be made more effective.

"We must stress at this point that EBC-46 will only be trialled in the short-term for tumours which can be accessed by direct injection or topical application," Dr Boyle said.

"There is no evidence to suggest EBC-46 would be effective against metastatic cancers."

The pre-clinical trials at QIMR Berghofer have been largely funded by QBiotics with additional support from the NHMRC.

Explore further: New clues to aggressive breast cancer

More information: Boyle GM, D'Souza MMA, Pierce CJ, Adams RA, Cantor AS, et al. (2014) "Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models." PLoS ONE 9(10): e108887. DOI: 10.1371/journal.pone.0108887

Related Stories

New clues to aggressive breast cancer

November 12, 2013
(Medical Xpress)—Queensland scientists have identified a genetic "switch" which indicates whether a woman's breast cancer will spread.

Targeted treatment could halt womb cancer growth

September 30, 2014
A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer.

New ways to treat solid tumours

August 15, 2014
(Medical Xpress)—An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects. 

New trick for 'old' drug brings hope for pancreatic cancer patients

August 3, 2014
Cancer Research UK scientists have found a new use for an old drug by showing that it shrinks a particular type of pancreatic cancer tumour and stops it spreading, according to research published in Gut.

Eighty percent of bowel cancers halted with existing medicines

October 1, 2014
(Medical Xpress)—An international team of scientists has shown that more than 80 per cent of bowel cancers could be treated with existing drugs.

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

halloweenhouseparty
not rated yet Oct 09, 2014
sounds too good to be true.
iloveseble
not rated yet Oct 10, 2014
"...from the seeds of a rainforest plant." At least you're promoting, kinda, the idea that plants can destroy cancer (yes, in animals so far). What does that mean for the Australian rain forests? Deforestation for agribusiness has reached seriously alarming heights.

Know what else has been shown to kill cancer--in humans? A whole foods, plant-based diet. No rain forests destroyed, skyrocketing methane levels (agribusiness is #1 cause of climate change) drop, as does our weight, blood pressure, cholesterol, chances of getting cancer, heart disease, type II diabetes, having a stroke...just about every disease out there that involves inflammation.

I take a cancer drug for my RA (!!); horrible side effects. So Big Pharma comes out with another cancer drug that lessens the horrible side effects of the first drug (methotrexate--TOXIC). Am I the only one who finds this insane? The US is the most heavily medicated country in the world. And we're sicker and fatter than ever. Drugs failing.
iloveseble
not rated yet Oct 10, 2014
"...from the seeds of a rainforest plant." At least you're promoting, kinda, the idea that plants can destroy cancer (yes, in animals so far). What does that mean for the Australian rain forests? Deforestation for agribusiness has reached seriously alarming heights.

Know what else has been shown to kill cancer--in humans? A whole foods, plant-based diet. No rain forests destroyed, skyrocketing methane levels (agribusiness is #1 cause of climate change) drop, as does our weight, blood pressure, cholesterol, chances of getting cancer, heart disease, type II diabetes, having a stroke...just about every disease out there that involves inflammation.

I take a cancer drug for my RA (!!); horrible side effects. So Big Pharma comes out with another cancer drug that lessens the horrible side effects of the first drug (methotrexate--TOXIC). Am I the only one who finds this insane? The US is the most heavily medicated country in the world. And we're sicker and fatter than ever. Drugs failing.
xartaart
not rated yet Oct 14, 2014
4 years ago (2010) the article about the same drug said it would be tested in humans in 2011 but in 2014 they are still in preclinical tests fase...
It sounds like the researchers made this announcement in effort to find money and i quote a part of the 2010 article ..."and hopes to raise enough funds to begin human trials in 2011"

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.